Adjuvant nivolumab (NIVO) vs ipilimumab (IPI) in resected stage III/IV melanoma: 4-y recurrence-free and overall survival (OS) results from CheckMate 238

Simple item page
dc.conference.dateSEP 19-OCT 18, 2020
dc.conference.titleESMO Virtual Congress
dc.contributor.authorWeber, J.
dc.contributor.authorDel Vecchio, M.
dc.contributor.authorMandala, M.
dc.contributor.authorGogas, H.
dc.contributor.authorArance Fernandez, A. M.
dc.contributor.authorDalle, S.
dc.contributor.authorCowey, C. L.
dc.contributor.authorSchenker, M.
dc.contributor.authorGrob, J-J.
dc.contributor.authorSileni, V. Chiarion
dc.contributor.authorMarquez-Rodas, I.
dc.contributor.authorButler, M. O.
dc.contributor.authorMaio, M.
dc.contributor.authorMiddleton, M.
dc.contributor.authorde la Cruz Merino, L.
dc.contributor.authorLobo, M.
dc.contributor.authorde Pril, V.
dc.contributor.authorLarkin, J.
dc.contributor.authorAscierto, P. A.
dc.contributor.authoraffiliation[Weber, J.] NYU Langone Perlmutter Canc Ctr, Med Oncol, New York, NY USA
dc.contributor.authoraffiliation[Del Vecchio, M.] Fdn IRCCS Ist Nazl Tumori, Melanoma Med Oncol Unit, Milan, Italy
dc.contributor.authoraffiliation[Mandala, M.] Papa Giovanni XIII Hosp, Oncol Unit, Bergamo, Italy
dc.contributor.authoraffiliation[Gogas, H.] Natl & Kapodistrian Univ Athens, Dept Internal Med, Athens, Greece
dc.contributor.authoraffiliation[Arance Fernandez, A. M.] Hosp Clin Barcelona, Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Dalle, S.] Hosp Civils Lyon, Dept Dermatol, Pierre Benite, France
dc.contributor.authoraffiliation[Cowey, C. L.] Baylor A Charles Sammons Canc Ctr, Texas Oncol, Med Oncol, Dallas, TX USA
dc.contributor.authoraffiliation[Schenker, M.] Oncol Ctr Sf Nectarie Ltd, Oncol Ctr, Craiova, Romania
dc.contributor.authoraffiliation[Grob, J-J.] Hop La Timone, Dermatol, Marseille, France
dc.contributor.authoraffiliation[Sileni, V. Chiarion] Veneto Inst Oncol IOV IRCCS, Melanoma Oncol Unit, Padua, Italy
dc.contributor.authoraffiliation[Marquez-Rodas, I.] Gen Univ Hosp Gregorio Maranon, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Butler, M. O.] Princess Margaret Canc Ctr, Med Oncol & Hematol Dept, Toronto, ON, Canada
dc.contributor.authoraffiliation[Maio, M.] Azienda Osped Univ Senese Santa Maria delle Scott, Ctr Immunooncol, Siena, Italy
dc.contributor.authoraffiliation[Middleton, M.] Univ Oxford, Dept Oncol, Oxford, England
dc.contributor.authoraffiliation[de la Cruz Merino, L.] Hosp Univ Virgen Macarena, Dept Med, Seville, Spain
dc.contributor.authoraffiliation[Lobo, M.] Bristol Myers Squibb, Clin Res, Princeton, NJ USA
dc.contributor.authoraffiliation[de Pril, V.] Bristol Myers Squibb, Clin Res, Princeton, NJ USA
dc.contributor.authoraffiliation[Larkin, J.] Royal Marsden NHS Fdn Trust, Dept Med, London, England
dc.contributor.authoraffiliation[Ascierto, P. A.] Ist Nazl Tumori IRCCS Fdn Pascale, Melanoma Canc Immunotherapy & Dev Therapeut, Naples, Italy
dc.contributor.funderBristol-Myers Squibb Company
dc.date.accessioned2025-01-07T16:00:17Z
dc.date.available2025-01-07T16:00:17Z
dc.date.issued2020-09-01
dc.identifier.doi10.1016/j.annonc.2020.08.1200
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S0923753420411962/pdf
dc.identifier.urihttps://hdl.handle.net/10668/27550
dc.identifier.wosID573469101364
dc.issue.number4
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.organizationSAS - Hospital Universitario Virgen Macarena
dc.page.numberS731-S732
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleAdjuvant nivolumab (NIVO) vs ipilimumab (IPI) in resected stage III/IV melanoma: 4-y recurrence-free and overall survival (OS) results from CheckMate 238
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number31
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Virgen del Rocío
SAS - Hospital Universitario Virgen Macarena

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía